The CDC recommends a five-dose series starting at the age of 2 months until age 6 ... The CDC recommends a one-time RSV vaccine for everyone over the age of 75 or select adults between the ages of 60 ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance for seniors. Carina Marquez, MD, associate professor of Medicine in ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

The flu and COVID-19 vaccines fit the "annual" bill for everyone over six months, and it's important to make an appointment ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

For adults aged 60 years or older, respiratory syncytial virus (RSV) vaccination is effective for preventing associat ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

More information: Angela R Branche, Real-world effectiveness studies of the benefit of RSV vaccines, The Lancet (2024).DOI: 10.1016/S0140-6736(24)02150-0 Amanda B Payne et al, Respiratory ...

Credit: Getty Images Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD. While adults with IBD face a 2-fold increased risk for RSV ...

Notably, quarterly sales of the company’s RSV vaccine, which became a blockbuster after debuting last year, fell by more than 70% year over year, in part due to narrower U.S. recommendations for ...